Navigation Links
Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied

NOAA/Virginia Sea Grant has awarded Virginia Tech $119,000 to study whether high hydrostatic pressure will inactivate Hepatitis A virus in both shucked and unshucked oysters.

The project, led by Daniel Holliman, an M.D. with the High Pressure Processing Laboratory, and Laura Douglas, lab manager, will identify one or more effective high pressure processing schedules. The laboratory is a facility of the Department of Food Science and Technology at Virginia Tech, devoted to improving food safety and food processing.

Hepatitis A virus (HAV) is one of the more serious illnesses transmissible by shellfish. Worldwide, HAV is responsible for more than 1.5 million cases of the disease each year, with 260,000 cases and more than 100 deaths in the United States. Hepatitis A infection is characterized by fatigue, malaise, fever, loss of appetite, nausea, vomiting, joint and muscle aches, and abdominal pain, coupled with the onset of jaundice, a yellowing of the whites of the eyes, and dark urine. The disease generally runs its course in two months, but can linger as long as six. While survival rates for Hepatitis A are above 99 percent, the disease can be very dangerous for infants, the elderly, immunosuppressed people, and those with existing liver disease.

Bivalve shellfish, such as oysters, have been demonstrated to concentrate pathogenic organisms from their environment. In some cases, sewage contamination of harvesting areas, either from coastal runoff or ship discharges, has been shown to result in HAV contamination of oysters. Several studies have demonstrated remarkable concentration and persistence of HAV in shellfish exposed to the virus through their surrounding seawater. Even with depuration, HAV may persist in oysters for several weeks after exposure. The virus also is fairly resistant to heating and may remain viable in shellfish after up to five minutes of steaming.

For these reasons, high hydrostatic pressure treatment of raw oyst ers is especially appealing to oyster processors and distributors, as well as public health officials. HPP makes it possible to eradicate or inactivate pathogens while still delivering a 'raw' product to the consumer.

The study will benefit processors and distributors by mitigating their food safety liability, but most importantly, also will help protect consumers from foodborne infectious disease.

Virginia Sea Grant is part of a 30-state National Sea Grant Program established by Congress in 1966 as part of the National Oceanic and Atmospheric Administration. Sea-grant colleges research new ideas and technologies to help use, manage, and understand ocean and coastal resources. Virginia Sea Grant funds marine science research in aquaculture, seafood safety and quality, marine resources, coastal ecosystems through a competitive, peer-reviewed grant proposal process. In addition to its core programs, Virginia Sea Grant coordinates research in oyster disease and toxics in the Chesapeake Bay.


'"/>

Source:Virginia Tech


Related biology news :

1. Gene therapy to lower blood pressure just enough
2. Researchers learn how blood vessel cells cope with their pressure-packed job
3. Genes affecting blood pressure change as children become adults
4. How nice, brown rice: Study shows rice bran lowers blood pressure in rats
5. Blame the brain for high blood pressure
6. Its OK for men with high blood pressure to have a drink or two, new study finds
7. 8 plants from South Africa may hold potential for treating high blood pressure
8. Scientists Replicate Hepatitis C Virus in Laboratory
9. Norovirus, AIDS vaccine and Hepatitis Virus
10. UCLA study assesses cost-effectiveness of Hepatitis B drugs
11. Natural Killers Could Lead to New Hepatitis Treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology: